123 related articles for article (PubMed ID: 23834332)
1. N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats.
González GE; Rhaleb NE; Nakagawa P; Liao TD; Liu Y; Leung P; Dai X; Yang XP; Carretero OA
Clin Sci (Lond); 2014 Jan; 126(1):85-94. PubMed ID: 23834332
[TBL] [Abstract][Full Text] [Related]
2. Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension.
Rasoul S; Carretero OA; Peng H; Cavasin MA; Zhuo J; Sanchez-Mendoza A; Brigstock DR; Rhaleb NE
J Hypertens; 2004 Mar; 22(3):593-603. PubMed ID: 15076166
[TBL] [Abstract][Full Text] [Related]
3. Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage.
Sharma U; Rhaleb NE; Pokharel S; Harding P; Rasoul S; Peng H; Carretero OA
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1226-32. PubMed ID: 18178715
[TBL] [Abstract][Full Text] [Related]
4. Ac-SDKP reverses cardiac fibrosis in rats with renovascular hypertension.
Peng H; Carretero OA; Brigstock DR; Oja-Tebbe N; Rhaleb NE
Hypertension; 2003 Dec; 42(6):1164-70. PubMed ID: 14581293
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors: a new mechanism of action.
Peng H; Carretero OA; Vuljaj N; Liao TD; Motivala A; Peterson EL; Rhaleb NE
Circulation; 2005 Oct; 112(16):2436-45. PubMed ID: 16216963
[TBL] [Abstract][Full Text] [Related]
6.
Peng H; Xu J; Yang XP; Kassem KM; Rhaleb IA; Peterson E; Rhaleb NE
Can J Physiol Pharmacol; 2019 Aug; 97(8):753-765. PubMed ID: 30998852
[TBL] [Abstract][Full Text] [Related]
7. Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats.
Cingolani OH; Yang XP; Liu YH; Villanueva M; Rhaleb NE; Carretero OA
Hypertension; 2004 May; 43(5):1067-73. PubMed ID: 15023934
[TBL] [Abstract][Full Text] [Related]
8. Characterization and localization of Ac-SDKP receptor binding sites using 125I-labeled Hpp-Aca-SDKP in rat cardiac fibroblasts.
Zhuo JL; Carretero OA; Peng H; Li XC; Regoli D; Neugebauer W; Rhaleb NE
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H984-93. PubMed ID: 17028162
[TBL] [Abstract][Full Text] [Related]
9. Ac-SDKP attenuates ER stress-stimulated collagen production in cardiac fibroblasts by inhibiting CHOP-mediated NF-κB expression.
Suhail H; Peng H; Matrougui K; Rhaleb NE
Front Pharmacol; 2024; 15():1352222. PubMed ID: 38495093
[TBL] [Abstract][Full Text] [Related]
10. N-acetyl-seryl-aspartyl-lysyl-proline stimulates angiogenesis in vitro and in vivo.
Wang D; Carretero OA; Yang XY; Rhaleb NE; Liu YH; Liao TD; Yang XP
Am J Physiol Heart Circ Physiol; 2004 Nov; 287(5):H2099-105. PubMed ID: 15256375
[TBL] [Abstract][Full Text] [Related]
11. Knockout of ACE-N facilitates improved cardiac function after myocardial infarction.
Suhail H; Peng H; Xu J; Sabbah HN; Matrougui K; Liao TD; Ortiz PA; Bernstein KE; Rhaleb NE
J Mol Cell Cardiol Plus; 2023 Mar; 3():. PubMed ID: 36778784
[TBL] [Abstract][Full Text] [Related]
12. Targeting Lysyl Oxidase as a Potential Therapeutic Approach to Reducing Fibrotic Scars Post-operatively: Its Biological Role in Post-Surgical Scar Development.
Sabbagh MG; Aliakbarian M; Khodashahi R; Ferns GA; Rahimi H; Ashrafzadeh K; Tavakkoli M; Arjmand MH
Curr Drug Targets; 2023; 24(14):1099-1105. PubMed ID: 37929723
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk of lysyl oxidase-like 1 and lysyl oxidase prolongs their half-lives and regulates liver fibrosis through Notch signal.
Zhang N; Yang A; Zhang W; Li H; Xu A; Yan X; Han Q; Wang B; You H; Chen W
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38466882
[TBL] [Abstract][Full Text] [Related]
14. Tβ4-Ac-SDKP pathway: Any relevance for the cardiovascular system?
Kassem KM; Vaid S; Peng H; Sarkar S; Rhaleb NE
Can J Physiol Pharmacol; 2019 Jul; 97(7):589-599. PubMed ID: 30854877
[TBL] [Abstract][Full Text] [Related]
15. Obesity induces adipose fibrosis and collagen cross-linking through suppressing AMPK and enhancing lysyl oxidase expression.
Liu X; Zhao L; Chen Y; Gao Y; Tian Q; Son JS; Chae SA; de Avila JM; Zhu MJ; Du M
Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166454. PubMed ID: 35644337
[TBL] [Abstract][Full Text] [Related]
16. Phospholipid Encapsulation of an Anti-Fibrotic Endopeptide to Enhance Cellular Uptake and Myocardial Retention.
Sonkawade SD; Xu S; Kim M; Nepali S; Karambizi VG; Sexton S; Turowski SG; Li K; Spernyak JA; Lovell JF; George A; Suwal S; Sharma UC; Pokharel S
Cells; 2023 Jun; 12(12):. PubMed ID: 37371059
[TBL] [Abstract][Full Text] [Related]
17. Ac-SDKP promotes KIF3A-mediated β-catenin suppression through a ciliary mechanism to constrain silica-induced epithelial-myofibroblast transition.
Liu S; Jin R; Zheng G; Wang Y; Li Q; Jin F; Li Y; Li T; Mao N; Wei Z; Li G; Fan Y; Xu H; Li S; Yang F
Biomed Pharmacother; 2023 Oct; 166():115411. PubMed ID: 37651800
[TBL] [Abstract][Full Text] [Related]
18. Scientific letter: Ac-SDKP (N-acetyl-seryl-aspartyl-lysyl-proline) and Galectin-3 levels in tuberculous pericardial effusion: implications for pathogenesis and prevention of pericardial constriction.
Ntsekhe M; Matthews K; Wolske J; Badri M; Wilkinson KA; Wilkinson RJ; Sturrock ED; Mayosi BM
Heart; 2012 Sep; 98(17):1326-8. PubMed ID: 22842991
[No Abstract] [Full Text] [Related]
19. Femtosecond laser-patterned nanopore arrays for surface-mediated peptide treatment.
Zachman AL; Hofmeister LH; Costa L; Boire TC; Hwang YS; Hofmeister WH; Sung HJ
Nanomedicine; 2014 Jan; 10(1):11-4. PubMed ID: 24090768
[TBL] [Abstract][Full Text] [Related]
20. Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms.
Bhatia D; Srivastava SP
Front Pharmacol; 2023; 14():1252315. PubMed ID: 37614315
[No Abstract] [Full Text] [Related]
[Next] [New Search]
